Multi-Organ Microphysiological Systems Targeting Specific Organs for Recapitulating Disease Phenotypes via Organ Crosstalk

被引:1
|
作者
Kim, Joeng Ju [1 ,2 ]
Bae, Mihyeon [1 ,2 ]
Cho, Dong-Woo [1 ,2 ]
机构
[1] Pohang Univ Sci & Technol POSTECH, Dept Mech Engn, Pohang 37673, Kyungbuk, South Korea
[2] POSTECH, POSTECH Catholic Biomed Engn Inst, Pohang 37673, Kyungbuk, South Korea
来源
SMALL SCIENCE | 2024年 / 4卷 / 11期
基金
新加坡国家研究基金会;
关键词
biofabrications; biomaterials; disease in vitro models; multi-organ microphysiological systems; organs on-a-chip; ON-A-CHIP; BRAIN AXIS; 3D; BIOMATERIALS; MODEL; MECHANISMS; PREVENTION; STRATEGIES; PLATFORM; BIOINKS;
D O I
10.1002/smsc.202400314
中图分类号
TB3 [工程材料学];
学科分类号
0805 ; 080502 ;
摘要
Various systemic metabolic diseases arise from prolonged crosstalk across multiple organs, triggering serious impairments in various physiological systems. These diseases are intricate systemic pathologies characterized by complex mechanisms and an unclear etiology, making the treatment challenging. Efforts have been made to develop in vitro models to understand these diseases and devise new treatments. However, there are limitations in reconstructing the causal relationships between diseases and interorgan crosstalk, including the tissue-specific microenvironment. Alternatively, multi-organ microphysiological systems (MOMPS) present new possibilities for capturing the complexity of systemic metabolic diseases by replicating human microphysiology and simulating diverse interorgan crosstalk. Controlled interactions and scalable representations of biological complexity in MOMPS offer a more accurate portrayal of organ interactions, enabling the identification of novel relationships between organ crosstalk, metabolism, and immunity. This, in turn, can yield valuable insights into disease mechanisms and drug development research and enhance the efficiency of preclinical studies. In this review, the examples and technical capabilities of MOMPS pathological modeling for various diseases are discussed, leveraging state-of-the-art biofabrication technology of MOMPS. It evaluates the current opportunities and challenges in this field. Multi-organ microphysiological systems (MOMPS) replicate human microphysiology and interorgan crosstalk. The precise fabrication of MOMPS requires various elements, including biomaterials, cell sources, accurate organ crosstalk, biofabrication techniques, and humanized design. The MOMPS enhances the understanding of systemic metabolic disease mechanisms, improves drug development, and increases the efficiency of preclinical studies by capturing the complexity of organ interactions and tissue-specific microenvironments..image (c) 2024 WILEY-VCH GmbH
引用
收藏
页数:23
相关论文
共 50 条
  • [21] Renewing our understanding of tuberculosis as a multi-organ disease
    Kuze, F
    INTERNAL MEDICINE, 1996, 35 (11) : 839 - 840
  • [22] An in vitro multi-organ microphysiological system (MPS) to investigate the gut-to-brain translocation of neurotoxins
    Jones, Emily J.
    Skinner, Benjamin M.
    Parker, Aimee
    Baldwin, Lydia R.
    Greenman, John
    Carding, Simon R.
    Funnell, Simon G. P.
    BIOMICROFLUIDICS, 2024, 18 (05)
  • [23] A Multi-Organ Microphysiological System that Models Dormant-Emergent Metastatic Breast Cancer Progression
    Clark, A. M.
    Dioufa, N.
    Chan, K.
    Edington, C. D.
    Kumar, M.
    Wheeler, S. E.
    Venkataramanan, R.
    Stolz, D. B.
    Trumper, D.
    Griffith, L.
    Lauffenburger, D.
    Wells, A.
    AMERICAN JOURNAL OF PATHOLOGY, 2017, 187 (10): : 2356 - 2356
  • [24] A computational analysis of dynamic, multi-organ inflammatory crosstalk induced by endotoxin in mice
    Zamora, Ruben
    Korff, Sebastian
    Mi, Qi
    Barclay, Derek
    Schimunek, Lukas
    Zucca, Riccardo
    Arsiwalla, Xerxes D.
    Simmons, Richard L.
    Verschure, Paul
    Billiar, Timothy R.
    Vodovotz, Yoram
    PLOS COMPUTATIONAL BIOLOGY, 2018, 14 (11)
  • [25] Epidemiological characteristics of a group of multi-organ donors used to transplant organs in Cuba
    Abdo-Cuza, A
    Suárez-Savio, O
    García-Navarro, ME
    Castenanos-Gutiérrez, R
    Gómez-Peyre, F
    Parellada-Blazco, J
    Alvarez-Plasencia, A
    Rafael-Truy, B
    Castellanos-Becerril, F
    Verdecia-Gorrita, N
    Howland-Alvarez, I
    Cruz-Gómez, Y
    REVISTA DE NEUROLOGIA, 2001, 33 (12) : 1117 - 1119
  • [26] Towards a whole-body systems [multi-organ] lipidomics in Alzheimer's disease
    Astarita, Giuseppe
    Piomelli, Daniele
    PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS, 2011, 85 (05): : 197 - 203
  • [27] Microphysiological system to address the opioid crisis: A novel multi-organ model of acute opioid overdose and recovery
    Patel, Aakash
    Poddar, Suruchi
    Nierenberg, Daniel
    Lang, Stephanie
    Wang, Hao
    Demello, Camilly Pestana Pires
    Gamarra, Julio
    Colon, Alisha
    Kennedy, Paula
    Roles, Jeffry
    Klion, Jules
    Bogen, Will
    Long, Christopher
    Guo, Xiufang
    Tighe, Patrick
    Schmidt, Stephan
    Shuler, Michael L.
    Hickman, James J.
    CURRENT RESEARCH IN TOXICOLOGY, 2025, 8
  • [28] Fabry Disease: From Dermatologic Entity to a Treatable Multi-Organ Disease
    Desnick, R. J.
    CLINICAL THERAPEUTICS, 2010, 32 : S90 - S92
  • [29] Multi-organ denervation: a novel approach to combat cardiometabolic disease
    Márcio Galindo Kiuchi
    Revathy Carnagarin
    Vance B. Matthews
    Markus P. Schlaich
    Hypertension Research, 2023, 46 : 1747 - 1758
  • [30] Multi-organ denervation: a novel approach to combat cardiometabolic disease
    Kiuchi, Marcio Galindo
    Carnagarin, Revathy
    Matthews, Vance B.
    Schlaich, Markus P.
    HYPERTENSION RESEARCH, 2023, 46 (07) : 1747 - 1758